Summary
This prospective study of 81,954 postmenopausal women used novel metabolomics-derived biomarkers to calibrate self-reported macronutrient intake, overcoming a long-standing limitation in dietary assessment. Higher carbohydrate density was associated with reduced risk of coronary heart disease, heart failure, breast cancer, and total cancer, whilst higher protein density was associated with increased type 2 diabetes risk. The use of objective biomarker calibration rather than uncorrected dietary recall provides more robust evidence for macronutrient-disease associations.
Regional applicability
This US-based study of postmenopausal women aged 50–79 years may have limited direct applicability to United Kingdom populations, which differ in age structure, ethnicity, and dietary patterns. However, the biomarker calibration methodology is transferable, and the findings regarding carbohydrate density and cardiovascular/cancer risk are relevant to UK dietary guidance if validated in European cohorts.
Key measures
Biomarker-calibrated protein density, carbohydrate density, and total energy intake (using doubly labeled water); incidence of coronary heart disease, heart failure, breast cancer, total invasive cancer, and type 2 diabetes
Outcomes reported
The study examined associations between biomarker-calibrated macronutrient intake (protein density and carbohydrate density) and incidence of cardiovascular disease, cancer, and type 2 diabetes over 20 years of follow-up in postmenopausal women. Primary outcomes included coronary heart disease and breast cancer, with secondary outcomes including heart failure and total invasive cancer.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.